Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk: An update meta-analysis and trial sequential analysis.

Abstract

AIM:

To evaluate the associations between the methylenetetrahydrofolate reductase (MTHFR) single-nucleotide polymorphisms (SNPs) and hepatocellular carcinoma (HCC) with meta-analysis and trial sequential analysis.

METHODS:

PubMed, Embase, the Google Scholar, Wan fang database, VIP database, and China National Knowledge Infrastructure were extensively searched before April 2021. Odds ratios (ORs) and 95% confidence interval (95% CI) were calculated. Review Manager Version 5.3, STATA version 12.0 and TSA 0.9.5.10 Beta software were used.

RESULTS:

Nineteen studies with 6941 HCC patients and 9436 controls were finally included. The MTHFR rs1801133 (C677T) SNP was associated with increased HCC risk under heterozygote genetic model (OR = 1.10, 95% CI = [1.01, 1.20]). For Subgroup analysis, increased risks of HCC were detected in Mongoloid, Chinese. For MTHFR rs1801131 (A1298C) SNP, increased risk of HCC was only observed in Caucasians (allelic: OR = 1.86, 95% CI = [1.49, 2.31]; homozygote: OR = 3.39, 95% CI = [2.18, 5.27]), interesting decreased risk was detected in Mongoloid (recessive: OR = 0.30, 95% CI = [0.15, 0.58]; homozygote: OR = 0.41, 95% CI = [0.24, 0.72]). Sensitivity analysis indicated stability in our results. Publication bias was not detected based on Begg test and Egger test. Trial sequential analysis indicated further studies to confirm the associations in MTHFR C677T polymorphism.

CONCLUSION:

The MTHFR rs1801133 SNP was associated with an increased risk of HCC in Mongoloid population especially in Chinese. Increased HCC risk is also observed in Caucasian population for the MTHFR rs1801131 SNP, and decreased risk of HCC is remarkably discovered in Mongoloid and Chinese subgroups, which need further validation.

• Authors: Binfeng Wang, Miaomiao Ma, Xiaojun Guo, Yan Yan, Lang Li
• Journal: Medicine (Medicine (Baltimore)) Vol. 100 Issue 41 Pg. e27527 (Oct 15 2021) ISSN: 1536-5964 [Electronic] United States
• PMID: 34731145 (Publication Type: Journal Article, Meta-Analysis)
• Copyright: Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Chemical References

• Methylenetetrahydrofolate Reductase (NADPH2)

Topics

• Asian People (genetics)
• Carcinoma, Hepatocellular (diagnosis, genetics)
• Case-Control Studies
• China (ethnology)
• Female
• Homozygote
• Humans
• Liver Neoplasms (pathology)
• Male
• Methylenetetrahydrofolate Reductase (NADPH2) (genetics)
• Polymorphism, Single Nucleotide (genetics)
• Risk Factors
• Sensitivity and Specificity
• Software
• White People (genetics)